1. Home
  2. MBIO vs FRSX Comparison

MBIO vs FRSX Comparison

Compare MBIO & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.59

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

N/A

Current Price

$1.30

Market Cap

4.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIO
FRSX
Founded
2015
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.0M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
MBIO
FRSX
Price
$0.59
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.7K
35.5K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.31
52 Week High
$1.84
$3.00

Technical Indicators

Market Signals
Indicator
MBIO
FRSX
Relative Strength Index (RSI) 45.62 41.61
Support Level $0.54 $1.21
Resistance Level $0.66 $1.47
Average True Range (ATR) 0.05 0.11
MACD 0.00 0.02
Stochastic Oscillator 50.89 53.88

Price Performance

Historical Comparison
MBIO
FRSX

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

Share on Social Networks: